GAMMA Investing LLC Purchases 49,477 Shares of Maximus, Inc. (NYSE:MMS)

GAMMA Investing LLC raised its holdings in shares of Maximus, Inc. (NYSE:MMS - Free Report) by 11,296.1% in the 1st quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 49,915 shares of the health services provider's stock after acquiring an additional 49,477 shares during the quarter. GAMMA Investing LLC owned approximately 0.09% of Maximus worth $3,404,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors also recently made changes to their positions in the business. Mirae Asset Global Investments Co. Ltd. acquired a new position in shares of Maximus during the 4th quarter worth approximately $1,113,000. Entropy Technologies LP raised its position in Maximus by 178.1% during the fourth quarter. Entropy Technologies LP now owns 6,383 shares of the health services provider's stock worth $476,000 after acquiring an additional 4,088 shares in the last quarter. Allspring Global Investments Holdings LLC lifted its stake in Maximus by 2.4% in the fourth quarter. Allspring Global Investments Holdings LLC now owns 722,172 shares of the health services provider's stock valued at $54,748,000 after acquiring an additional 16,772 shares during the last quarter. Legato Capital Management LLC increased its stake in shares of Maximus by 33.9% during the 4th quarter. Legato Capital Management LLC now owns 32,134 shares of the health services provider's stock worth $2,399,000 after purchasing an additional 8,138 shares during the last quarter. Finally, V Square Quantitative Management LLC raised its holdings in shares of Maximus by 65.9% in the 4th quarter. V Square Quantitative Management LLC now owns 453 shares of the health services provider's stock valued at $34,000 after purchasing an additional 180 shares during the period. 97.21% of the stock is currently owned by institutional investors and hedge funds.

Analyst Ratings Changes

Separately, Wall Street Zen downgraded Maximus from a "buy" rating to a "hold" rating in a report on Thursday, May 15th.

Maximus Stock Performance

MMS stock traded down $0.90 during mid-day trading on Friday, hitting $70.07. 134,830 shares of the company were exchanged, compared to its average volume of 565,227. Maximus, Inc. has a 1-year low of $63.77 and a 1-year high of $93.97. The business has a 50 day simple moving average of $70.37 and a 200-day simple moving average of $71.20. The company has a current ratio of 1.72, a quick ratio of 1.72 and a debt-to-equity ratio of 0.82. The stock has a market capitalization of $3.95 billion, a PE ratio of 15.07 and a beta of 0.62.

Maximus (NYSE:MMS - Get Free Report) last posted its quarterly earnings data on Thursday, May 8th. The health services provider reported $2.01 earnings per share for the quarter, topping the consensus estimate of $1.37 by $0.64. Maximus had a return on equity of 21.95% and a net margin of 5.28%. The firm had revenue of $1.36 billion for the quarter, compared to analysts' expectations of $1.29 billion. During the same quarter last year, the business earned $1.57 EPS. The company's quarterly revenue was up 1.0% compared to the same quarter last year. On average, equities analysts forecast that Maximus, Inc. will post 6.15 earnings per share for the current year.

Maximus Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Saturday, May 31st. Investors of record on Thursday, May 15th were paid a $0.30 dividend. This represents a $1.20 annualized dividend and a yield of 1.71%. The ex-dividend date was Thursday, May 15th. Maximus's dividend payout ratio (DPR) is presently 23.86%.

Insider Buying and Selling at Maximus

In other Maximus news, Director Gayathri Rajan sold 7,913 shares of the stock in a transaction dated Friday, May 30th. The stock was sold at an average price of $72.38, for a total value of $572,742.94. Following the completion of the transaction, the director now directly owns 14,205 shares in the company, valued at approximately $1,028,157.90. This trade represents a 35.78% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, Director Jan Madsen sold 2,439 shares of the firm's stock in a transaction that occurred on Tuesday, March 18th. The shares were sold at an average price of $67.71, for a total transaction of $165,144.69. Following the completion of the transaction, the director now owns 18,097 shares of the company's stock, valued at approximately $1,225,347.87. This trade represents a 11.88% decrease in their position. The disclosure for this sale can be found here. Company insiders own 1.60% of the company's stock.

Maximus Company Profile

Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.